Welcome to our dedicated page for YORKU news (Ticker: YORKU), a resource for investors and traders seeking the latest updates and insights on YORKU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect YORKU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of YORKU's position in the market.
Yorkville Acquisition Corp. (NASDAQ:YORKU) has announced the pricing of its initial public offering (IPO) of 15 million units at $10.00 per unit, totaling $150 million. Each unit comprises one Class A ordinary share and one-third of one redeemable warrant, with whole warrants exercisable at $11.50 per share.
The units will begin trading on Nasdaq under "YORKU" on June 27, 2025. Upon separation, shares and warrants will trade under "YORK" and "YORKW" respectively. Clear Street is serving as the sole book-running manager, with a 45-day over-allotment option for an additional 2.25 million units. The offering is expected to close on June 30, 2025.
